Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline IMXI Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges ZOOZ Q2 2025 Earnings EPS Misses Estimates Stock Rises 876 BKV Q1 2026 Earnings Earnings Miss Expectations as EPS Falls Short CYD Q3 2020 Earnings Modest EPS Miss Amidst Stabilizing Operations